Polymer nanoparticles are excellent materials for nucleic acid drug delivery because of their biodegradability, water solubility, biocompatibility, biomimetic properties, and storage stability. CD Formulation has developed a polymer-based nanoparticle delivery system platform for clients, offering professional solutions for nucleic acid drug delivery and expediting drug research progress.
Polymer nanomaterials exhibit diverse drug delivery capabilities. Drugs can be encapsulated within the nanomaterials, wrapped in polymer molecules, chemically bonded to the polymers, or attached to the surface of the nanomaterials. This versatility enables the delivery of both hydrophobic and hydrophilic compounds. By modifying the composition, stability, responsiveness, and surface charge of the polymer nanomaterials, researchers can precisely control the drug loading capacity and release kinetics.
Polymer Delivery Carriers
Fig.1 Polymer-based drug delivery systems. (Ding L, et al., 2024)
CD Formulation offers a diverse range of polymer-based nanoparticle delivery systems designed for the administration of various types of nucleic acid drugs. Leveraging the unique properties and benefits of polymers, we provide the following types of polymer drug delivery platforms:
Polymer microspheres are typically composed of biodegradable polymers, such as PLGA (poly(lactic-co-glycolic acid)), which can encapsulate nucleic acid drugs, enhancing their efficacy and stability through controlled release.
Formed from block copolymers, these nanomicelles can encapsulate hydrophobic drugs within their hydrophobic core while simultaneously enclosing hydrophilic nucleic acids in the hydrophilic shell. This structure enhances the stability and bioavailability of the drugs and nucleic acids in vivo.
These nanoparticles can be produced using various methods, such as nanoprecipitation and emulsion-solvent evaporation, to facilitate the efficient delivery of nucleic acid drugs.
Formed through the electrostatic interaction between cationic polymers and anionic nucleic acids, these self-assembled complexes play a crucial role in protecting and delivering nucleic acid-based drugs.
Highly branched synthetic polymers with multiple terminal functionalities can be utilized for the encapsulation and delivery of nucleic acid drugs, thereby enhancing their stability and delivery efficiency in vivo.
As an innovative delivery system, polymer nanomaterials have emerged as essential tools for nucleic acid drug delivery, owing to their exceptional biocompatibility, tunability, and biodegradability. By harnessing the unique properties of polymers, CD Formulation consistently explores and optimizes various types of polymer nanomaterials to develop efficient and safe nucleic acid delivery solutions.
After selecting the appropriate polymers, adjusting the ratio of polymer to nucleic acid can optimize encapsulation efficiency and enhance particle characteristics.
Technologies such as electrospinning are employed to blend polymer solutions with nucleic acids, resulting in the formation of uniform nanoparticles.
Introducing targeting ligands, such as antibodies or peptides, on the surface of nanoparticles or coating them with materials like polyethylene oxide (PEO) enhances cellular selectivity and uptake efficiency while increasing biocompatibility and reducing immune responses.
A variety of characterization techniques are employed to assess the properties of polymer nanoparticles and to quantitatively analyze the encapsulation efficiency of nucleic acid drugs.
CD Formulation's polymer nanoparticle drug delivery platform offers specialized and reliable services to support you at every stage of nucleic acid drug development.
Technology: Polymeric nanoparticles platform for drug delivery
Journal: Nature reviews drug discovery
IF: 122.7
Published: 2021
Results:
As lipid-based, polymeric, and inorganic nanoparticles become more specifically designed, they can begin to optimize drug delivery in a more personalized manner, thus entering the era of precision medicine. In this review, the authors will discuss advanced nanoparticle designs used in both non-personalized and precision applications that can be used to improve precision therapies. Focusing on advances in nanoparticle design that overcome the barriers to heterogeneous drug delivery, the authors argue that smart nanoparticle design can improve efficacy in general drug delivery applications while providing tailored designs for precision applications, which can ultimately improve patient outcomes across the board.
Fig.2 Classes of polymer nanoparticles. (Mitchell M J, et al., 2021)
CD Formulation's polymer nanoparticle drug delivery platform offers high-end support for your research and clinical applications. Contact us, and we can help you overcome challenges in drug delivery.
References